Stockreport

Institutional Capital Returns as This Microcap Biotech Locks In Fresh Funding [Globe and Mail, The (Toronto, Canada)]

Scinai Immunotherapeutics Ltd. - American Depositary Shares  (SCNI) 
PDF That trend has started to shift as targeted institutional money moves back into select names, particularly in immunology, inflammation therapeutics, and the contract dev [Read more]